A purple and pink letter v on a white background.
August 4, 2021

Tips On Treating Transgender Clients For Aesthetic Clinics

Transgender clients are a growing demographic among aesthetic patients, but still face adversity when seeking out treatments. Along with hormones and surgery, transgender clients are increasingly looking to aesthetic treatments to achieve their physical goals, and a 2021 study confirmed the importance of non-invasive procedures to meet this need. Medical aesthetics can help transgender clients not only look their best, but also attain what medical literature calls ‘ gender euphoria’, a sense of profound rightness and accuracy in one’s experience of gender. The first step on this journey is ensuring that transgender clients who come to you have a positive clinic experience. Here are several key considerations for communication with trans and non-binary clients for both medical professionals and office staff.

There's No Substitute F or Training

Your clients need their clinic experience to be affirming, sensitive and inclusive from start to finish. Consider seeking training for your whole staff in the cultural competency required for dealing with this vulnerable community. Look into training based on cultural humility, an approach that urges us to maintain openness and honest acceptance when faced with unfamiliar cultures—and remain open to learning even more as you go.  

Be As Inviting A s Possible

 

Many of the long-term treatments for gender dysphoria require passing through several gatekeeping experiences; for example, your clients may have had to undertake mandatory therapy in order to determine if they are sufficiently transgender to warrant medical intervention. This process can be exhausting and alienating. It is important to remember that seeking medical aesthetics is an act of vulnerability, especially for those who have dealt with bias from medical professionals. Your front desk staff in particular should be familiar with the needs of the trans community and the kind of negative experiences they may have had in the past. Do your best to create an environment of immediate and unconditional acceptance for your transgender clientele.

 

The Right Language Is Key

Get to know your client’s pronouns and ask them how they would like to be addressed. Bias can be embedded in the language we use, including medical terms. Clients should always be referred to by the pronouns they choose. Intake paperwork should request “ gender ” rather than “sex”, and in addition to the binary masculine and feminine, include an option for “other”. Although this is partly for insurance purposes, the DSM-5 still refers to transgender clients as having a diagnosable condition. The now-defunct diagnosis of “gender identity disorder” has been replaced by “gender dysphoria”. This subtle change reorients the perspective on the diagnosis away from pathologizing the trans identity and towards the lack of bodily congruence: the issue isn’t that the gender is “wrong” but, rather, that the body needs treatment to match it properly.

Don't Make Assumptions

It may be easy to assume that a client seeking medical aesthetic treatment for gender dysphoria is also planning for hormone treatment or surgical intervention. However, this is not always the case. Many transgender people do not see a need for surgery, and exclusively want cosmetic or aesthetic modifications. Some clients may be early in their explorations of gender, and seeking help exploring their identity through modifications such as reshaping, hair restoration, or hair removal. Other clients may be in their preparation stages for surgery, and seeking pre-operative interventions for body hair, shape, and appearance. Be open to meeting your client wherever they are in their journey, and allow them to set the boundaries for what changes they are and are not seeking.

Always Be Listening

Clients may be “in the closet” about their gender identity still and present as their assigned gender (i.e. a transgender woman still wearing her “male” clothing); however, be certain to use affirming names and pronouns as appropriate, no matter how they are obligated to present. Also, not all transgender individuals subscribe to a binary male/female model of gender. A person may seek a treatment to appear more feminine without necessarily wishing to transition to female. Let your clients tell you who they are and what they need.

Aesthetic Treatment Options F or Transgender Clients

Even with hormone therapy and surgery, 84% of transgender individuals still report concerns about their appearance, such as excess facial and body hair, that create a feeling of gender dysphoria. Similarly, while hormonal treatment will modify the way the body allocates muscle and fat, trans people often seek body shaping to maximize the success of this process. This may include surgical treatments on the belly, hips, chest, shoulders, and more; however, the market for non-surgical treatments for reshaping the changing trans body is undeniable.

Venus Concept offers a suite of treatment platforms that can help your trans clientele achieve their goals of gender euphoria:

For education, training, and support in the ever-changing world of medical aesthetics, Venus Concept is here for you. Reach out to speak to one of our experts today.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.